<p /><p /><p /><p>KUALA LUMPUR: The Health Ministry conducted 12 raids from 2025 to September on retatrutide, an experimental weight-loss drug not registered in Malaysia, seizing 697 units worth RM341,000, Health Minister Datuk Seri Dr Dzulkefly Ahmad said.
Key takeaways
Malaysia's Health Ministry seized over RM405,000 worth of unregistered weight-loss drugs, including retatrutide and Ozempic, during 19 recent raids. Officials stated they will continue monitoring e-commerce platforms to ensure public safety and drug efficacy.
- Twelve raids seized 697 units of unregistered retatrutide worth RM341,000.
- Seven raids seized 62 units of unauthorised Ozempic worth RM64,170.
- Retatrutide is an investigational drug in Phase 3 trials with no global approval.
Summarised automatically by AI from the original article by New Straits Times. AI can make mistakes, so check the original for details.
KUALA LUMPUR: The Health Ministry conducted 12 raids from 2025 to September on retatrutide, an experimental weight-loss drug not registered in Malaysia, seizing 697 units worth RM341,000, Health Minister Datuk Seri Dr Dzulkefly Ahmad said.
"It (retatrutide) is not yet in our formulary," he told the Dewan Rakyat here.
A further seven raids targeted Ozempic or semaglutide sold without authorisation, with 62 units worth RM64,170 seized.
Dzulkefly was replying during an oral question-and-answer session to Datuk Seri Dr Zaliha Mustafa (PH-Sekijang), who said GLP-1 products were very effective and promoted by influencers on TikTok, but sold online without control.
